Paradigm Biopharmaceutic... (PK) Quote - PBIGF | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Paradigm Biopharmaceuticals Ltd (PK) (PBIGF) Share Price

Paradigm Biopharmaceuticals Ltd (PK) (PBIGF)

0.1405

0.00

(0.00%)

Closed November 24 3:00PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

0.1405

Bid

0.1404

Ask

0.2547

Volume

-

0.00 Day's Range 0.00

0.1147 52 Week Range 0.2738

Market Cap

Previous Close

0.1405

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

12,001

Shares Outstanding

349,795,939

Dividend Yield

-

PE Ratio

-2.21

Earnings Per Share (EPS)

-0.17

Revenue

6.11M

Net Profit

-58.65M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.paradigmbiopharma.com

Headquarters

Melbourne, Victoria, Aus

Founded

-

Paradigm Biopharmaceuticals Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PBIGF. The last closing price for Paradigm Biopharmaceutic... (PK) was US$0.14. Over the last year, Paradigm Biopharmaceutic... (PK) shares have traded in a share price range of US$ 0.1147 to US$ 0.2738.

Paradigm Biopharmaceutic... (PK) currently has 349,795,939 shares outstanding. The market capitalization of Paradigm Biopharmaceutic... (PK) is US$49.15 million. Paradigm Biopharmaceutic... (PK) has a price to earnings ratio (PE ratio) of -2.21.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0.0196	16.211745244	0.1209	0.1405	0.1209	30534	0.1405	CS
12	-0.03126	-18.1998136935	0.17176	0.17176	0.1147	12001	0.1419803	CS
26	-0.0495	-26.0526315789	0.19	0.19	0.1147	6930	0.16390626	CS
52	-0.11825	-45.7004830918	0.25875	0.2738	0.1147	8058	0.17368647	CS
156	-1.4596	-91.2192987938	1.6001	1.6001	0.1147	5094	0.52221227	CS
260	-2.402238	-94.4744602079	2.542738	3	0.1147	4630	0.82602919	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NEPTFNeptune Wellness Solutions Inc (CE)	US$ 0.0238 (2,379,900.00%)	13.46k
CNVIFConavi Medical Corporation (PK)	US$ 0.58 (82,757.14%)	2.25k
FUNFFFansUnite Entertainment Inc (CE)	US$ 0.00055 (54,900.00%)	342.7k
RQHTFReliq Health Technologies Inc (CE)	US$ 0.0003 (29,900.00%)	219.11k
ELOXEloxx Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	1.53k
FDVXFFenixOro Gold Corporation (CE)	US$ 0.000001 (-100.00%)	10k
TMPOQTempo Automation Holdings Inc (CE)	US$ 0.000001 (-99.98%)	200
HLLPFHello Pal International Inc (CE)	US$ 0.000001 (-99.90%)	6k
MOTSMotus GI Holdings Inc (CE)	US$ 0.000001 (-99.88%)	649
BTAEFBeta Energy Corporation (CE)	US$ 0.000001 (-99.67%)	655
RSHNRushNet Inc (PK)	US$ 0.00015 (-25.00%)	502.31M
EARIEntertainment Arts Research Inc (PK)	US$ 0.0001 (0.00%)	428.38M
ASTAAstra Veda Corporation (PK)	US$ 0.0002 (-33.33%)	364.38M
RDARRaadr Inc (PK)	US$ 0.0009 (50.00%)	276.07M
CGACCode Green Apparel Corp (PK)	US$ 0.00065 (44.44%)	225.16M

Fred Kadiddlehopper

Fred Kadiddlehopper 3 minutes ago

I disagree. Stopping a potential competitor like Alteogen in its tracks would benefit Halozyme immensely, IMHO.

OMOLIVES

OMOLIVES 3 minutes ago

lol....no. It doesn't work like that.

https://www.merriam-webster.com/dictionary/support

I certainly do not have a problem with the pick because it is not something that needs to be solved. Therefor, it is not a problem.

$GROO

$GROO 3 minutes ago

your hubris and hatred for Franky, blinds you of the value of saving human lives, around 50% of many dispensaries have gray or counterfeit produfts. you will be judged by the all mighty.

janga

janga 3 minutes ago

I thought you'd like this: https://www.ccn.com/news/business/gold-prices-rise-discovery-china-new-record-ahead/

delerious1

delerious1 3 minutes ago

This rally is off the charts, as far as I can see it's pure Fundamentals now ...charts are in the rear view mirror

biotechinvestor1

biotechinvestor1 6 minutes ago

Decease and desist that you referred to in your message, would not benefit Halozyme. Halo would much rather have either a license fee or some penalty for infringement. The only real entity that would benefit from a C and desist would be brystol Myers, in which case they would be back in Halozyme wi

AJH92

AJH92 6 minutes ago

Share Structure - Updated November 23, 2024

Transfer Agent Verified

No change - no dilution

Authorized Shares: 2,400,000,000

Outstanding Shares: 2,115,876,871

Restricted: 186,002,437

Unrestricted: 1,929,874,434

OncoJock

OncoJock 7 minutes ago

Thank you for posting this.

-- OJ

Fred Kadiddlehopper

Fred Kadiddlehopper 7 minutes ago

To your point, though, it is possible that BMY might be willing to chip in to the HALO legal fund in order to slow or otherwise hamper SC Keytruda's entry into the marketplace, thus strengthening HALO's hand.

OMOLIVES

OMOLIVES 8 minutes ago

I never said it did. And i was replying to Hawks regarding the quote and link coming from some TV guy...which OZ became. As in the guy is just jealous of Oz's carreer. Which is obviously is..lol.

jimr1717

jimr1717 9 minutes ago

India? Why no news in the US? I think I know why.

AJH92

AJH92 9 minutes ago

Share Structure - Updated November 18, 2024:

Transfer Agent Verified

No change - no dilution

Authorized Shares: 12,000,000,000

Outstanding Shares: 3,142,243,272

Restricted: 383,572,035

Unrestricted: 2,758,671,2

Jack Torrance

Jack Torrance 9 minutes ago

2025 is shaping up to be a good year. I am in several tickers that seem set to explode in the next 12 months or so.

Jim Beem

Jim Beem 10 minutes ago

Gotta be tuff pretending to others this is still a winner when clearly it's a loser.

SEC DELINQUENT NOTICE ON ASII

Horseman Country

Horseman Country 10 minutes ago

I chat with "the bot" on the phone several times a week...but carry on Mr. Sunshine.

TradingCharts

TradingCharts 11 minutes ago

25 November 2024
Successfulsoil program develops new targets at the
West Wodgina Lithium Project
Highlights
https://clients3.weblink.com.au/pdf/SYA/02884949.pdf
5 targets identified with Li2O assays up to 255ppm from successful soil sampling program
New tar

AJH92

AJH92 11 minutes ago

Share Structure - Updated November 23, 2024

Transfer Agent Verified

Authorized Shares: 3,000,000,000

Outstanding Shares: 13,224,737

- Restricted: 8,269,251

- Unrestricted: 4,955,486

TradingCharts

TradingCharts 12 minutes ago

25 November 2024
Successfulsoil program develops new targets at the
West Wodgina Lithium Project
Highlights
https://clients3.weblink.com.au/pdf/SYA/02884949.pdf
5 targets identified with Li2O assays up to 255ppm from successful soil sampling program
New tar

jimr1717

jimr1717 12 minutes ago

Lot YGF1 is ready for harvest

tat4tat

tat4tat 13 minutes ago

Tomorrow will be the beginning of YUGE MASSIVE move for share price.

crescentmotor

crescentmotor 13 minutes ago

What is hard to understand is why someone spends so much time bashing a company

Hoskuld is not an AVXL basher in my opinion as I believe his criticisms are valid and can be backed up by facts. If you think Hoskuld bashes AVXL, I can't imagine how I am supposed to feel about his comm

Clark6290

Clark6290 13 minutes ago

The bot is AI, has no shares. Sorry fella . Find a real hero

Fred Kadiddlehopper

Fred Kadiddlehopper 13 minutes ago

You are assuming that HALO's only recourse is to ask for a cut of the royalties. One might assume HALO could, in the alternative, gain a cease-and-desist order before SC Keytruda ever makes it to market. Thus, Merck has skin in the game, and they are not going to be passively watching from the sidel

kund

kund 13 minutes ago

So much talk about what Misleading coulda, woulda, shoulda done. Misleading is an arrogant buffoon who will never learn his lesson. Any other company would have course-corrected after the Avatar failure, but he did nothing for Excellence and now has designed one of the tiniest trials for 3-71. "The

Paradigm Biopharmaceutic... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions